Status: Recruiting
Study of Tacrolimus Melt-Dose® for Lung Transplant Patients
To evaluate, under usual clinical practice conditions and with a 12-month follow-up , the most relevant pharmacokinetic parameters of tacrolimus metabolism and safety, in patients with recent lung transplant (unilateral or bilateral) treated with LCPT.
Participants needed: 240
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Chiesi España, S.A.U.Updated: Jun 27, 2025Locations: 2
Eligibility criteria
Patients ≥18 years old. [+4]
Patients who have received a multi-organ transplant or have a history of any org... [+9]